Star Imaging and Path Lab
Star Imaging and Path Lab (STARIMAGIN) share price was ₹74.70 at the 28 Oct 2026 close; market capitalisation ₹130 Cr; sector Healthcare Services. The share price fell 43.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹43 Cr, against ₹41 Cr a year earlier and net profit was ₹9 Cr, against ₹10 Cr a year earlier (compared with Mar 2025). Promoters held 71.92% of Star Imaging and Path Lab in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 61/100 (Good) as of 28 Oct 2026.
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹1,908.40 | 59.01 | 32,032 Cr | 12.77 | 0.26% | 20.06% | 25.67% | 2,996 Cr | 545 Cr | |
| ₹1,438.20 | 78.89 | 14,813 Cr | 15.48 | 0.14% | 18.07% | 19.22% | 879 Cr | 187 Cr | |
| ₹548.70 | 56.39 | 11,379 Cr | 7.58 | 0.91% | 12.54% | 15.73% | 1,733 Cr | 203 Cr | |
| ₹514.75 | 46.46 | 8,193 Cr | 15.98 | 2.84% | 27.79% | 33.84% | 894 Cr | 176 Cr | |
| ₹629.60 | 150.26 | 6,331 Cr | 5.67 | 0.00% | 6.88% | 13.46% | 1,079 Cr | 85 Cr | |
| ₹318.55 | 46.30 | 1,659 Cr | 6.78 | 0.16% | 12.90% | 14.70% | 329 Cr | 35 Cr | |
| ₹497.00 | 16.30 | 1,612 Cr | 1.64 | 0.40% | 10.35% | 10.64% | 862 Cr | 98 Cr | |
| — | — | 130 Cr | 1.12 | 0.00% | 16.58% | 22.60% | — | — | |
| Median 8 companies | ₹548.70 | 56.39 | 7,262 Cr | 7.18 | 0.21% | 14.74% | 17.48% | 894 Cr | 176 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 81/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Stock is trading at 1.17 times its book value
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.1%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 212 days.
- Working capital days have increased from 97.5 days to 146 days
Technical Indicators
Oscillators
Neutral
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 37% · Mar 2026
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 43 | 41 | 45 | 43 |
| Expenses | 31 | 24 | 28 | 27 |
| Operating Profit | 12 | 17 | 17 | 16 |
| OPM % | 27% | 41% | 38% | 37% |
| Other Income | 0 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 |
| PBT | 8 | 13 | 14 | 13 |
| Tax % | 25% | 26% | 26% | 28% |
| Net Profit | 6 | 10 | 10 | 9 |
| EPS (₹) | 4.6 | 7.19 | 5.77 | 5.3 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 69 | 58 | 79 | 82 | 86 |
| Expenses | 54 | 52 | 55 | 53 | 53 |
| Operating Profit | 15 | 6 | 23 | 29 | 33 |
| OPM % | 21% | 10% | 30% | 35% | 39% |
| Other Income | 0 | 0 | 1 | 0 | 1 |
| Interest | 2 | 2 | 3 | 3 | 2 |
| Depreciation | 4 | 3 | 5 | 5 | 6 |
| PBT | 9 | 1 | 16 | 21 | 26 |
| Tax % | 33% | 35% | 23% | 26% | 27% |
| Net Profit | 6 | 1 | 12 | 16 | 19 |
| EPS (₹) | 4.66 | 0.43 | 9.2 | 11.8 | 11.07 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 99 |
| Borrowings | 30 | 27 | 31 | 33 | 21 |
| Other Liabilities | 10 | 16 | 20 | 18 | 17 |
| Total Liabilities | 58 | 61 | 82 | 98 | 154 |
| Fixed Assets | 15 | 19 | 22 | 21 | 25 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 43 | 42 | 60 | 77 | 128 |
| Total Assets | 58 | 61 | 82 | 98 | 154 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 14 | 5 | 18 | -3 | 23 |
| Investing | -4 | -7 | -7 | -7 | -13 |
| Financing | -7 | -5 | 2 | 0 | 36 |
| Net Cash Flow | 3 | -7 | 13 | -10 | 46 |
| Free Cash Flow | 10 | -2 | 11 | -7 | 13 |
| CFO/EBITDA | 119 | 95 | 95 | 10 | 91 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 85 | 110 | 152 | 226 | 212 |
| Cash Conversion Cycle | 85 | 110 | 152 | 226 | 212 |
| Working Capital Days | 6 | -13 | 23 | 124 | 146 |
| ROCE % | — | 6% | 34% | 34% | 26% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Star Imaging and Path Lab insights
56 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about Star Imaging and Path Lab
What does Star Imaging and Path Lab Ltd do?
Where is Star Imaging and Path Lab Ltd (STARIMAGIN) listed?
Which sector does Star Imaging and Path Lab Ltd belong to?
What is the market capitalisation of Star Imaging and Path Lab Ltd?
What is the 52-week high and low of Star Imaging and Path Lab Ltd?
What is the Return on Equity (ROE) of Star Imaging and Path Lab Ltd?
Company Information
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544482.md for Star Imaging and Path Lab Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.